These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31715459)
1. Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases. Pilz G; Steger R; Wipfler P; Otto F; Afazel S; Haschke-Becher E; Trinka E; Harrer A J Neuroimmunol; 2020 Jan; 338():577087. PubMed ID: 31715459 [TBL] [Abstract][Full Text] [Related]
2. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219 [TBL] [Abstract][Full Text] [Related]
3. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887 [TBL] [Abstract][Full Text] [Related]
4. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections. Pícha D; Moravcová L; Smíšková D J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636 [TBL] [Abstract][Full Text] [Related]
5. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691 [TBL] [Abstract][Full Text] [Related]
6. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. Rupprecht TA; Lechner C; Tumani H; Fingerle V Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168 [TBL] [Abstract][Full Text] [Related]
7. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U; Mygland A J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children. Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475 [TBL] [Abstract][Full Text] [Related]
11. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6. Leth TA; Dessau RB; Møller JK Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639 [TBL] [Abstract][Full Text] [Related]
13. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360 [No Abstract] [Full Text] [Related]
14. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629 [TBL] [Abstract][Full Text] [Related]
15. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134 [TBL] [Abstract][Full Text] [Related]
17. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study. Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371 [TBL] [Abstract][Full Text] [Related]
18. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients. Wagner JN; Weis S; Kubasta C; Panholzer J; von Oertzen TJ J Neurol; 2018 Jan; 265(1):74-81. PubMed ID: 29134272 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study. Pilz G; Wipfler P; Otto F; Hitzl W; Afazel S; Haschke-Becher E; Trinka E; Harrer A J Neuroinflammation; 2019 Jan; 16(1):13. PubMed ID: 30660201 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis. Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]